CANOPY GROWTH CORP (CGC) Fundamental Analysis & Valuation

NASDAQ:CGC • CA1380357048

Current stock price

1.02 USD
-0.05 (-4.67%)
At close:
1.03 USD
+0.01 (+0.98%)
After Hours:

This CGC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. CGC Profitability Analysis

1.1 Basic Checks

  • CGC had negative earnings in the past year.
  • CGC had a negative operating cash flow in the past year.
  • In the past 5 years CGC always reported negative net income.
  • CGC had a negative operating cash flow in each of the past 5 years.
CGC Yearly Net Income VS EBIT VS OCF VS FCFCGC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -1B -2B -3B

1.2 Ratios

  • CGC has a Return On Assets (-29.52%) which is in line with its industry peers.
  • CGC has a Return On Equity (-43.07%) which is in line with its industry peers.
Industry RankSector Rank
ROA -29.52%
ROE -43.07%
ROIC N/A
ROA(3y)-83.37%
ROA(5y)-56.25%
ROE(3y)-219.63%
ROE(5y)-143.17%
ROIC(3y)N/A
ROIC(5y)N/A
CGC Yearly ROA, ROE, ROICCGC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100 -200 -300 -400

1.3 Margins

  • CGC has a Gross Margin of 26.56%. This is comparable to the rest of the industry: CGC outperforms 56.25% of its industry peers.
  • CGC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.56%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CGC Yearly Profit, Operating, Gross MarginsCGC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600 -800

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. CGC Health Analysis

2.1 Basic Checks

  • CGC does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for CGC has been increased compared to 1 year ago.
  • Compared to 5 years ago, CGC has less shares outstanding
  • CGC has a better debt/assets ratio than last year.
CGC Yearly Shares OutstandingCGC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M
CGC Yearly Total Debt VS Total AssetsCGC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • CGC has an Altman-Z score of -9.08. This is a bad value and indicates that CGC is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -9.08, CGC is not doing good in the industry: 69.27% of the companies in the same industry are doing better.
  • CGC has a Debt/Equity ratio of 0.32. This is a healthy value indicating a solid balance between debt and equity.
  • CGC has a Debt to Equity ratio (0.32) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Altman-Z -9.08
ROIC/WACCN/A
WACC11.9%
CGC Yearly LT Debt VS Equity VS FCFCGC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

2.3 Liquidity

  • CGC has a Current Ratio of 5.34. This indicates that CGC is financially healthy and has no problem in meeting its short term obligations.
  • CGC has a Current ratio of 5.34. This is in the better half of the industry: CGC outperforms 67.19% of its industry peers.
  • CGC has a Quick Ratio of 4.26. This indicates that CGC is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of CGC (4.26) is better than 64.06% of its industry peers.
Industry RankSector Rank
Current Ratio 5.34
Quick Ratio 4.26
CGC Yearly Current Assets VS Current LiabilitesCGC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. CGC Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 63.98% over the past year.
  • CGC shows a small growth in Revenue. In the last year, the Revenue has grown by 0.59%.
  • CGC shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -7.57% yearly.
EPS 1Y (TTM)63.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.78%
Revenue 1Y (TTM)0.59%
Revenue growth 3Y-19.22%
Revenue growth 5Y-7.57%
Sales Q2Q%-0.29%

3.2 Future

  • The Earnings Per Share is expected to grow by 15.29% on average over the next years. This is quite good.
  • Based on estimates for the next years, CGC will show a small growth in Revenue. The Revenue will grow by 4.95% on average per year.
EPS Next Y92.11%
EPS Next 2Y40.17%
EPS Next 3Y25.31%
EPS Next 5Y15.29%
Revenue Next Year3.35%
Revenue Next 2Y3.76%
Revenue Next 3Y3.7%
Revenue Next 5Y4.95%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CGC Yearly Revenue VS EstimatesCGC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M 500M
CGC Yearly EPS VS EstimatesCGC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 -20 -40 -60

More info and screens

Find the best growth stocksShow best growing peers

1

4. CGC Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CGC. In the last year negative earnings were reported.
  • Also next year CGC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CGC Price Earnings VS Forward Price EarningsCGC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CGC Per share dataCGC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1

4.3 Compensation for Growth

  • A more expensive valuation may be justified as CGC's earnings are expected to grow with 25.31% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.17%
EPS Next 3Y25.31%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CGC Dividend Analysis

5.1 Amount

  • No dividends for CGC!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CGC Fundamentals: All Metrics, Ratios and Statistics

CANOPY GROWTH CORP

NASDAQ:CGC (3/18/2026, 8:00:00 PM)

After market: 1.03 +0.01 (+0.98%)

1.02

-0.05 (-4.67%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-06
Earnings (Next)05-28
Inst Owners11.04%
Inst Owner Change43.02%
Ins Owners0.16%
Ins Owner Change5.21%
Market Cap412.20M
Revenue(TTM)278.39M
Net Income(TTM)-326.58M
Analysts47.69
Price Target1.81 (77.45%)
Short Float %7.12%
Short Ratio2.21
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-99.18%
Min EPS beat(2)-292.16%
Max EPS beat(2)93.8%
EPS beat(4)2
Avg EPS beat(4)-99.19%
Min EPS beat(4)-292.16%
Max EPS beat(4)93.8%
EPS beat(8)2
Avg EPS beat(8)-136.84%
EPS beat(12)3
Avg EPS beat(12)-180.14%
EPS beat(16)3
Avg EPS beat(16)-182.69%
Revenue beat(2)1
Avg Revenue beat(2)-2.39%
Min Revenue beat(2)-7.76%
Max Revenue beat(2)2.99%
Revenue beat(4)3
Avg Revenue beat(4)3.11%
Min Revenue beat(4)-7.76%
Max Revenue beat(4)9.57%
Revenue beat(8)5
Avg Revenue beat(8)2.85%
Revenue beat(12)7
Avg Revenue beat(12)2.61%
Revenue beat(16)8
Avg Revenue beat(16)-0.76%
PT rev (1m)-27.27%
PT rev (3m)-33.51%
EPS NQ rev (1m)-145%
EPS NQ rev (3m)-145%
EPS NY rev (1m)-47.64%
EPS NY rev (3m)-53.68%
Revenue NQ rev (1m)2.15%
Revenue NQ rev (3m)4.14%
Revenue NY rev (1m)1.18%
Revenue NY rev (3m)1.18%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.03
P/FCF N/A
P/OCF N/A
P/B 0.75
P/tB 0.89
EV/EBITDA N/A
EPS(TTM)-1.37
EYN/A
EPS(NY)-0.15
Fwd EYN/A
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)-0.14
OCFYN/A
SpS0.5
BVpS1.37
TBVpS1.15
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -29.52%
ROE -43.07%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 26.56%
FCFM N/A
ROA(3y)-83.37%
ROA(5y)-56.25%
ROE(3y)-219.63%
ROE(5y)-143.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 20.34%
Cap/Sales 2.87%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.34
Quick Ratio 4.26
Altman-Z -9.08
F-Score5
WACC11.9%
ROIC/WACCN/A
Cap/Depr(3y)15.39%
Cap/Depr(5y)45.04%
Cap/Sales(3y)2.72%
Cap/Sales(5y)9.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)63.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.78%
EPS Next Y92.11%
EPS Next 2Y40.17%
EPS Next 3Y25.31%
EPS Next 5Y15.29%
Revenue 1Y (TTM)0.59%
Revenue growth 3Y-19.22%
Revenue growth 5Y-7.57%
Sales Q2Q%-0.29%
Revenue Next Year3.35%
Revenue Next 2Y3.76%
Revenue Next 3Y3.7%
Revenue Next 5Y4.95%
EBIT growth 1Y56.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year85.42%
EBIT Next 3Y29.14%
EBIT Next 5Y18.15%
FCF growth 1Y78.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y80.31%
OCF growth 3YN/A
OCF growth 5YN/A

CANOPY GROWTH CORP / CGC Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CANOPY GROWTH CORP?

ChartMill assigns a fundamental rating of 2 / 10 to CGC.


What is the valuation status of CANOPY GROWTH CORP (CGC) stock?

ChartMill assigns a valuation rating of 1 / 10 to CANOPY GROWTH CORP (CGC). This can be considered as Overvalued.


What is the profitability of CGC stock?

CANOPY GROWTH CORP (CGC) has a profitability rating of 1 / 10.


What is the financial health of CANOPY GROWTH CORP (CGC) stock?

The financial health rating of CANOPY GROWTH CORP (CGC) is 4 / 10.